(Q46140702)
Statements
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer (English)
K-L Garm Spindler
N Pallisgaard
A A Rasmussen
J Lindebjerg
D Crüger
scientific article published on 29 January 2009